Deaths in Children and Adolescents Associated With COVID-19 and MIS-C in the United States.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
11 2021
Historique:
accepted: 28 07 2021
pubmed: 14 8 2021
medline: 15 12 2021
entrez: 13 8 2021
Statut: ppublish

Résumé

To describe the demographics, clinical characteristics, and hospital course among persons <21 years of age with a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated death. We conducted a retrospective case series of suspected SARS-CoV-2-associated deaths in the United States in persons <21 years of age during February 12 to July 31, 2020. All states and territories were invited to participate. We abstracted demographic and clinical data, including laboratory and treatment details, from medical records. We included 112 SARS-CoV-2-associated deaths from 25 participating jurisdictions. The median age was 17 years (IQR 8.5-19 years). Most decedents were male (71, 63%), 31 (28%) were Black (non-Hispanic) persons, and 52 (46%) were Hispanic persons. Ninety-six decedents (86%) had at least 1 underlying condition; obesity (42%), asthma (29%), and developmental disorders (22%) were most commonly documented. Among 69 hospitalized decedents, common complications included mechanical ventilation (75%) and acute respiratory failure (82%). The sixteen (14%) decedents who met multisystem inflammatory syndrome in children (MIS-C) criteria were similar in age, sex, and race and/or ethnicity to decedents without MIS-C; 11 of 16 (69%) had at least 1 underlying condition. SARS-CoV-2-associated deaths among persons <21 years of age occurred predominantly among Black (non-Hispanic) and Hispanic persons, male patients, and older adolescents. The most commonly reported underlying conditions were obesity, asthma, and developmental disorders. Decedents with coronavirus disease 2019 were more likely than those with MIS-C to have underlying medical conditions.

Identifiants

pubmed: 34385349
pii: peds.2021-052273
doi: 10.1542/peds.2021-052273
pmc: PMC9837742
mid: NIHMS1860632
pii:
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Informations de copyright

Copyright © 2021 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103
pubmed: 24488779
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):790-794
pubmed: 32584797
JAMA Pediatr. 2021 Feb 1;175(2):176-184
pubmed: 33226415
JAMA Intern Med. 2021 Jan 1;181(1):131-134
pubmed: 32804192
JAMA Netw Open. 2020 Nov 2;3(11):e2030280
pubmed: 33252688
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):88-94
pubmed: 33476314
JAMA. 2021 Mar 2;325(9):823-824
pubmed: 33497433
JAMA. 2012 Feb 1;307(5):483-90
pubmed: 22253364
Pediatr Pulmonol. 2020 Aug;55(8):2115-2127
pubmed: 32519809
MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):289-292
pubmed: 33630823
Clin Infect Dis. 2021 Jun 1;72(11):e695-e703
pubmed: 32945846
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):449-455
pubmed: 33764961
MMWR Morb Mortal Wkly Rep. 2021 Apr 09;70(14):523-527
pubmed: 33830982
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1081-1088
pubmed: 32790664
Pediatrics. 2021 May;147(5):
pubmed: 33602802
J Pediatr. 2020 Aug;223:14-19.e2
pubmed: 32407719
Int J Infect Dis. 2021 Feb;103:246-256
pubmed: 33227520
Hosp Pediatr. 2021 Jan;11(1):71-78
pubmed: 33033078
MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):442-448
pubmed: 33764967
Pediatrics. 2021 Apr;147(4):
pubmed: 33419869
Disabil Health J. 2020 Jul;13(3):100942
pubmed: 32473875
MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):437-441
pubmed: 33764962
JAMA Netw Open. 2021 Apr 1;4(4):e215298
pubmed: 33835179
Pediatrics. 2020 Aug;146(2):
pubmed: 32457213
Clin Infect Dis. 2021 May 4;72(9):e206-e214
pubmed: 32674114
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1207-1213.e4
pubmed: 30339856
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
JAMA Pediatr. 2021 Apr 1;175(4):415-417
pubmed: 33427850
JAMA Pediatr. 2020 Sep 01;174(9):868-873
pubmed: 32392288
J Pediatr. 2020 Aug;223:199-203.e1
pubmed: 32405091
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):136-140
pubmed: 33507890
Pediatr Crit Care Med. 2020 Oct;21(10):e948-e953
pubmed: 32639466
J Med Entomol. 2016 Mar;53(2):250-61
pubmed: 26681789
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1324-1329
pubmed: 32941417
NCHS Data Brief. 2017 Nov;(291):1-8
pubmed: 29235982

Auteurs

David W McCormick (DW)

Coronavirus Disease 2019 Response Team yup1@cdc.gov.
Epidemic Intelligence Service.

LaTonia Clay Richardson (LC)

Coronavirus Disease 2019 Response Team.

Paul R Young (PR)

Coronavirus Disease 2019 Response Team.

Laura J Viens (LJ)

Coronavirus Disease 2019 Response Team.

Carolyn V Gould (CV)

Coronavirus Disease 2019 Response Team.

Anne Kimball (A)

Coronavirus Disease 2019 Response Team.
Epidemic Intelligence Service.

Talia Pindyck (T)

Coronavirus Disease 2019 Response Team.

Hannah G Rosenblum (HG)

Coronavirus Disease 2019 Response Team.
Epidemic Intelligence Service.

David A Siegel (DA)

Coronavirus Disease 2019 Response Team.

Quan M Vu (QM)

Coronavirus Disease 2019 Response Team.

Ken Komatsu (K)

Arizona Department of Health Services, Phoenix, Arizona.

Heather Venkat (H)

Arizona Department of Health Services, Phoenix, Arizona.
Career Epidemiology Field Officer Program, Centers for Disease Control and Prevention, Atlanta, Georgia.

John J Openshaw (JJ)

California Department of Public Health, Sacramento, California.

Breanna Kawasaki (B)

Colorado Department of Public Health and Environment, Denver, Colorado.

Alan J Siniscalchi (AJ)

State of Connecticut Department of Public Health, Hartford, Connecticut.

Megan Gumke (M)

Florida Department of Health, Tallahassee, Florida.

Andrea Leapley (A)

Florida Department of Health, Tallahassee, Florida.

Melissa Tobin-D'Angelo (M)

Georgia Department of Public Health, Atlanta, Georgia.

Judy Kauerauf (J)

Illinois Department of Public Health, Springfield, Illinois.

Heather Reid (H)

Illinois Department of Public Health, Springfield, Illinois.

Kelly White (K)

Indiana Department of Health, Indianapolis, Indiana.

Farah S Ahmed (FS)

Kansas Department of Health and Environment, Topeka, Kansas.

Gillian Richardson (G)

Louisiana Department of Health, Baton Rouge, Louisiana.

Julie Hand (J)

Louisiana Department of Health, Baton Rouge, Louisiana.

Kim Kirkey (K)

Michigan Department of Health and Human Services, Lansing, Michigan.

Linnea Larson (L)

Minnesota Department of Health, Saint Paul, Minnesota.

Paul Byers (P)

Mississippi State Department of Health, Jackson, Mississippi.

Ali Garcia (A)

Nevada Department of Health and Human Services, Carson City, Nevada.

Mojisola Ojo (M)

New Jersey Department of Health, Trenton, New Jersey.

Ariela Zamcheck (A)

New York State Department of Health, Albany, New York.

Maura K Lash (MK)

New York City Department of Health and Mental Hygiene, New York City, New York.

Ellen H Lee (EH)

New York City Department of Health and Mental Hygiene, New York City, New York.

Kathleen H Reilly (KH)

New York City Department of Health and Mental Hygiene, New York City, New York.

Erica Wilson (E)

North Carolina Department of Health and Human Services, Raleigh, North Carolina.

Sietske de Fijter (S)

Ohio Department of Health, Columbus, Ohio.

Ozair H Naqvi (OH)

Oklahoma State Department of Health, Oklahoma City, Oklahoma.

Laurel Harduar-Morano (L)

Career Epidemiology Field Officer Program, Centers for Disease Control and Prevention, Atlanta, Georgia.
Pennsylvania Department of Health, Harrisburg, Pennsylvania.

Anna-Kathryn Burch (AK)

South Carolina Department of Health and Environmental Control, Columbia, South Carolina.

Adele Lewis (A)

Tennessee Department of Health, Nashville, Tennessee.

Jonathan Kolsin (J)

Texas Department of State Health Services, Austin, Texas.

Stephen J Pont (SJ)

Texas Department of State Health Services, Austin, Texas.

Bree Barbeau (B)

Utah Department of Health, Salt Lake City, Utah.

Danae Bixler (D)

Coronavirus Disease 2019 Response Team.

Sarah Reagan-Steiner (S)

Coronavirus Disease 2019 Response Team.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH